These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37506472)

  • 1. FAT10 differentially stabilizes MYPT2 isoforms.
    Song SE; Kim Y; Jeong H; Lee B; Lee J; Roh JS; So MW; Lee SG; Sohn DH
    Biochem Biophys Res Commun; 2023 Oct; 676():115-120. PubMed ID: 37506472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart.
    Okamoto R; Kato T; Mizoguchi A; Takahashi N; Nakakuki T; Mizutani H; Isaka N; Imanaka-Yoshida K; Kaibuchi K; Lu Z; Mabuchi K; Tao T; Hartshorne DJ; Nakano T; Ito M
    Cell Signal; 2006 Sep; 18(9):1408-16. PubMed ID: 16431080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ.
    Grassie ME; Moffat LD; Walsh MP; MacDonald JA
    Arch Biochem Biophys; 2011 Jun; 510(2):147-59. PubMed ID: 21291858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
    J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J; Groettrup M; Aichem A
    PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MYPT2-regulated striated muscle-specific myosin light chain phosphatase limits cardiac myosin phosphorylation in vivo.
    Lee E; May H; Kazmierczak K; Liang J; Nguyen N; Hill JA; Gillette TG; Szczesna-Cordary D; Chang AN
    J Biol Chem; 2024 Feb; 300(2):105652. PubMed ID: 38224947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new isoform of human myosin phosphatase targeting/regulatory subunit (MYPT2): cDNA cloning, tissue expression, and chromosomal mapping.
    Fujioka M; Takahashi N; Odai H; Araki S; Ichikawa K; Feng J; Nakamura M; Kaibuchi K; Hartshorne DJ; Nakano T; Ito M
    Genomics; 1998 Apr; 49(1):59-68. PubMed ID: 9570949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAT10ylation as a signal for proteasomal degradation.
    Schmidtke G; Aichem A; Groettrup M
    Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin light chain phosphatase catalytic subunit dephosphorylates cardiac myosin via mechanisms dependent and independent of the MYPT regulatory subunits.
    Lee E; Liu Z; Nguyen N; Nairn AC; Chang AN
    J Biol Chem; 2022 Sep; 298(9):102296. PubMed ID: 35872014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.
    Boehm AN; Bialas J; Catone N; Sacristan-Reviriego A; van der Spuy J; Groettrup M; Aichem A
    J Biol Chem; 2020 Oct; 295(42):14402-14418. PubMed ID: 32817338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
    Aichem A; Catone N; Groettrup M
    FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basis for the isoform-specific interaction of myosin phosphatase subunits protein phosphatase 1c beta and myosin phosphatase targeting subunit 1.
    Scotto-Lavino E; Garcia-Diaz M; Du G; Frohman MA
    J Biol Chem; 2010 Feb; 285(9):6419-24. PubMed ID: 20042605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ubiquitin-like Protein FAT10 Stabilizes eEF1A1 Expression to Promote Tumor Proliferation in a Complex Manner.
    Liu X; Chen L; Ge J; Yan C; Huang Z; Hu J; Wen C; Li M; Huang D; Qiu Y; Hao H; Yuan R; Lei J; Yu X; Shao J
    Cancer Res; 2016 Aug; 76(16):4897-907. PubMed ID: 27312528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin phosphatase: structure, regulation and function.
    Ito M; Nakano T; Erdodi F; Hartshorne DJ
    Mol Cell Biochem; 2004 Apr; 259(1-2):197-209. PubMed ID: 15124925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-like modifier FAT10 - much more than a proteasome-targeting signal.
    Aichem A; Groettrup M
    J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32719056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of myosin phosphatase reduces Ca(2+) sensitivity of contraction and impairs cardiac function.
    Mizutani H; Okamoto R; Moriki N; Konishi K; Taniguchi M; Fujita S; Dohi K; Onishi K; Suzuki N; Satoh S; Makino N; Itoh T; Hartshorne DJ; Ito M
    Circ J; 2010 Jan; 74(1):120-8. PubMed ID: 19966500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin Light Chain Phosphatase Plays an Important Role in Cardiac Fibrosis in a Model of Mineralocorticoid Receptor-Associated Hypertension.
    Ye Z; Okamoto R; Ito H; Ito R; Moriwaki K; Ichikawa M; Kimena L; Ali Y; Ito M; Gomez-Sanchez CE; Dohi K
    J Am Heart Assoc; 2024 Mar; 13(5):e032828. PubMed ID: 38420846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
    Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myosin light chain phosphatase: subunit composition, interactions and regulation.
    Hartshorne DJ; Ito M; Erdödi F
    J Muscle Res Cell Motil; 1998 May; 19(4):325-41. PubMed ID: 9635276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatase regulatory subunit MYPT2 knockout partially compensates for the cardiac dysfunction in mice caused by lack of myosin light chain kinase 3.
    Hu T; Kalyanaraman H; Pilz RB; Casteel DE
    J Biol Chem; 2023 Apr; 299(4):104584. PubMed ID: 36889588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.